| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |